TIAA FSB’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-6,469
| Closed | -$227K | – | 580 |
|
2022
Q4 | $227K | Sell |
6,469
-1,174
| -15% | -$41.3K | ﹤0.01% | 520 |
|
2022
Q3 | $225K | Sell |
7,643
-343
| -4% | -$10.1K | ﹤0.01% | 518 |
|
2022
Q2 | $435K | Buy |
+7,986
| New | +$435K | ﹤0.01% | 431 |
|
2021
Q3 | – | Sell |
-9,002
| Closed | -$448K | – | 384 |
|
2021
Q2 | $448K | Buy |
9,002
+568
| +7% | +$28.3K | ﹤0.01% | 359 |
|
2021
Q1 | $377K | Sell |
8,434
-4,060
| -32% | -$181K | ﹤0.01% | 347 |
|
2020
Q4 | $575K | Buy |
+12,494
| New | +$575K | ﹤0.01% | 322 |
|
2020
Q3 | – | Sell |
-16,172
| Closed | -$824K | – | 274 |
|
2020
Q2 | $824K | Sell |
16,172
-1,041
| -6% | -$53K | ﹤0.01% | 248 |
|
2020
Q1 | $815K | Sell |
17,213
-6,369
| -27% | -$302K | ﹤0.01% | 236 |
|
2019
Q4 | $1.39M | Buy |
23,582
+481
| +2% | +$28.3K | 0.01% | 245 |
|
2019
Q3 | $1.23M | Sell |
23,101
-129
| -0.6% | -$6.89K | 0.01% | 244 |
|
2019
Q2 | $1.16M | Buy |
23,230
+1,619
| +7% | +$81K | 0.01% | 235 |
|
2019
Q1 | $1.13M | Sell |
21,611
-518
| -2% | -$27.1K | 0.01% | 255 |
|
2018
Q4 | $1.06M | Sell |
22,129
-140
| -0.6% | -$6.69K | 0.01% | 257 |
|
2018
Q3 | $1.12M | Buy |
22,269
+349
| +2% | +$17.5K | 0.01% | 271 |
|
2018
Q2 | $1.1M | Sell |
21,920
-1,473
| -6% | -$74.2K | 0.01% | 270 |
|
2018
Q1 | $1.14M | Sell |
23,393
-54
| -0.2% | -$2.64K | 0.01% | 270 |
|
2017
Q4 | $1.04M | Sell |
23,447
-4,400
| -16% | -$195K | 0.01% | 308 |
|
2017
Q3 | $1.41M | Sell |
27,847
-289
| -1% | -$14.7K | 0.01% | 276 |
|
2017
Q2 | $1.52M | Buy |
+28,136
| New | +$1.52M | 0.01% | 259 |
|